PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $295,000 | -9.5% | 87,815 | -15.4% | 0.00% | -33.3% |
| Q2 2016 | $326,000 | +126.4% | 103,845 | +261.2% | 0.00% | – |
| Q3 2015 | $144,000 | -72.0% | 28,752 | -64.0% | 0.00% | -100.0% |
| Q2 2015 | $514,000 | +93.2% | 79,801 | +110.8% | 0.00% | +200.0% |
| Q1 2015 | $266,000 | -19.1% | 37,855 | -11.3% | 0.00% | -50.0% |
| Q4 2014 | $329,000 | +232.3% | 42,675 | +221.7% | 0.00% | +100.0% |
| Q3 2014 | $99,000 | -45.9% | 13,265 | -29.8% | 0.00% | -50.0% |
| Q2 2014 | $183,000 | -35.6% | 18,900 | -44.7% | 0.00% | 0.0% |
| Q1 2014 | $284,000 | -58.5% | 34,200 | -57.8% | 0.00% | -60.0% |
| Q4 2013 | $685,000 | -12.2% | 81,100 | -19.7% | 0.01% | +66.7% |
| Q2 2013 | $780,000 | – | 101,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |